Revenue: The sum of all revenue fields included for a company's operating activities.
Mereo BioPharma Group plc - Sponsored ADR (MREO) Revenue data is not available for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
-- |
$-12.89M |
|
-- |
|
-- |
|
$11.20M |
|
$-11.20M |
|
$-1.69M |
|
$-12.89M |
|
$-12.89M |
|
$-12.89M |
|
$-12.89M |
|
$-12.89M |
|
$-12.89M |
|
$-11.20M |
|
$-11.06M |
|
156.86M |
|
156.86M |
|
$-0.08 |
|
$-0.08 |
|
| Balance Sheet Financials | |
$66.90M |
|
$0.25M |
|
$1.42M |
|
$68.32M |
|
$7.50M |
|
-- |
|
$0.74M |
|
$8.24M |
|
$60.08M |
|
$59.53M |
|
$60.08M |
|
159.00M |
|
| Cash Flow Statement Financials | |
$-8.33M |
|
$-0.32M |
|
$0.42M |
|
$69.80M |
|
$62.48M |
|
$-7.32M |
|
$2.28M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.92 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.35M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-21.45% |
|
-21.65% |
|
-18.86% |
|
-21.45% |
|
$0.38 |
|
$-0.05 |
|
$-0.05 |
|